Spironolactone Use and the Risk of Breast Cancer
April 2016
in “
Journal of The American Academy of Dermatology
”
Studysummary Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on doi.org →